Market Cap 3.90B
Revenue (ttm) 130.13M
Net Income (ttm) -260.60M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -200.26%
Debt to Equity Ratio 0.00
Volume 757,300
Avg Vol 759,486
Day's Range N/A - N/A
Shares Out 63.62M
Stochastic %K 85%
Beta 2.36
Analysts Strong Sell
Price Target $81.08

Latest News on RYTM

Rhythm Pharmaceuticals: Buying This Rare Genetic Obesity Maven

Feb 25, 2025, 11:21 AM EST - 3 months ago

Rhythm Pharmaceuticals: Buying This Rare Genetic Obesity Maven


Three Biotech Stocks to Buy for the "Golden Age of Medicine"

Aug 19, 2024, 1:49 PM EDT - 10 months ago

Three Biotech Stocks to Buy for the "Golden Age of Medicine"

LLY SNY